Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

The heart-placenta axis in the first month of pregnancy: induction and prevention of cardiovascular birth defects.

Linask KK.

J Pregnancy. 2013;2013:320413. doi: 10.1155/2013/320413. Epub 2013 Apr 17.

2.

When should we prescribe high-dose folic acid to prevent congenital heart defects?

Huhta JC, Linask K.

Curr Opin Cardiol. 2015 Jan;30(1):125-31. doi: 10.1097/HCO.0000000000000124. Review.

PMID:
25389654
3.

Acute alcohol exposure during mouse gastrulation alters lipid metabolism in placental and heart development: Folate prevention.

Linask KK, Han M.

Birth Defects Res A Clin Mol Teratol. 2016 Sep;106(9):749-60. doi: 10.1002/bdra.23526. Epub 2016 Jun 14.

4.

Folate rescues lithium-, homocysteine- and Wnt3A-induced vertebrate cardiac anomalies.

Han M, Serrano MC, Lastra-Vicente R, Brinez P, Acharya G, Huhta JC, Chen R, Linask KK.

Dis Model Mech. 2009 Sep-Oct;2(9-10):467-78. doi: 10.1242/dmm.001438. Epub 2009 Jul 28.

5.

Folate protection from congenital heart defects linked with canonical Wnt signaling and epigenetics.

Linask KK, Huhta J.

Curr Opin Pediatr. 2010 Oct;22(5):561-6. doi: 10.1097/MOP.0b013e32833e2723. Review.

6.

Fetal alcohol syndrome: cardiac birth defects in mice and prevention with folate.

Serrano M, Han M, Brinez P, Linask KK.

Am J Obstet Gynecol. 2010 Jul;203(1):75.e7-75.e15. doi: 10.1016/j.ajog.2010.03.017. Epub 2010 May 10.

PMID:
20451895
7.

Complex cardiac defects after ethanol exposure during discrete cardiogenic events in zebrafish: prevention with folic acid.

Sarmah S, Marrs JA.

Dev Dyn. 2013 Oct;242(10):1184-201. doi: 10.1002/dvdy.24015. Epub 2013 Sep 2.

8.
9.

Gene expression profiling in the fetal cardiac tissue after folate and low-dose trichloroethylene exposure.

Caldwell PT, Manziello A, Howard J, Palbykin B, Runyan RB, Selmin O.

Birth Defects Res A Clin Mol Teratol. 2010 Feb;88(2):111-27. doi: 10.1002/bdra.20631.

10.

Periconceptional Folic Acid Supplementation and Infant Risk of Congenital Heart Defects in Norway 1999-2009.

Leirgul E, Gildestad T, Nilsen RM, Fomina T, Brodwall K, Greve G, Vollset SE, Holmstrøm H, Tell GS, Øyen N.

Paediatr Perinat Epidemiol. 2015 Sep;29(5):391-400. doi: 10.1111/ppe.12212. Epub 2015 Jul 24.

PMID:
26212116
11.

The association between periconceptional folic acid supplementation and congenital heart defects: a case-control study in China.

Li X, Li S, Mu D, Liu Z, Li Y, Lin Y, Chen X, You F, Li N, Deng K, Deng Y, Wang Y, Zhu J.

Prev Med. 2013 Jun;56(6):385-9. doi: 10.1016/j.ypmed.2013.02.019. Epub 2013 Feb 26.

PMID:
23480969
12.

Functional interactions between the LRP6 WNT co-receptor and folate supplementation.

Gray JD, Nakouzi G, Slowinska-Castaldo B, Dazard JE, Rao JS, Nadeau JH, Ross ME.

Hum Mol Genet. 2010 Dec 1;19(23):4560-72. doi: 10.1093/hmg/ddq384. Epub 2010 Sep 15.

13.

Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation.

van Beynum IM, Kapusta L, den Heijer M, Vermeulen SH, Kouwenberg M, Daniëls O, Blom HJ.

Eur Heart J. 2006 Apr;27(8):981-7. Epub 2006 Mar 7.

PMID:
16524890
14.

Folic acid in pregnant women associated with reduced prevalence of severe congenital heart defects in their children: a national population-based case-control study.

Czeizel AE, Vereczkey A, Szabó I.

Eur J Obstet Gynecol Reprod Biol. 2015 Oct;193:34-9. doi: 10.1016/j.ejogrb.2015.06.024. Epub 2015 Jul 9.

PMID:
26225846
15.

Maternal occupational exposure to polycyclic aromatic hydrocarbons and congenital heart defects among offspring in the national birth defects prevention study.

Lupo PJ, Symanski E, Langlois PH, Lawson CC, Malik S, Gilboa SM, Lee LJ, Agopian AJ, Desrosiers TA, Waters MA, Romitti PA, Correa A, Shaw GM, Mitchell LE; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2012 Nov;94(11):875-81. doi: 10.1002/bdra.23071. Epub 2012 Sep 3.

16.

Environmental origins of congenital heart disease: the heart-placenta connection.

Huhta J, Linask KK.

Semin Fetal Neonatal Med. 2013 Oct;18(5):245-50. doi: 10.1016/j.siny.2013.05.003. Epub 2013 Jun 7. Review.

PMID:
23751925
17.
18.

Methylenetetrahydrofolate reductase deficiency and low dietary folate increase embryonic delay and placental abnormalities in mice.

Pickell L, Li D, Brown K, Mikael LG, Wang XL, Wu Q, Luo L, Jerome-Majewska L, Rozen R.

Birth Defects Res A Clin Mol Teratol. 2009 Jun;85(6):531-41. doi: 10.1002/bdra.20575.

PMID:
19215022
19.

A Meta-Analysis of the Relationship Between Maternal Folic Acid Supplementation and the Risk of Congenital Heart Defects.

Xu A, Cao X, Lu Y, Li H, Zhu Q, Chen X, Jiang H, Li X.

Int Heart J. 2016 Dec 2;57(6):725-728. Epub 2016 Nov 9.

20.

Conotruncal heart defects and common variants in maternal and fetal genes in folate, homocysteine, and transsulfuration pathways.

Hobbs CA, Cleves MA, Macleod SL, Erickson SW, Tang X, Li J, Li M, Nick T, Malik S; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2014 Feb;100(2):116-26. doi: 10.1002/bdra.23225. Epub 2014 Feb 18.

Supplemental Content

Support Center